Global Cholesterol Tests Market 2022 - Snapshot

The global cholesterol tests market was estimated at USD 1,585 million in 2021 and is expected to hit USD 2,496 million by 2028, registering a CAGR of 6.7% from 2022 to 2028 as per the latest report by Gen Consulting Company.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, and region. The global market data on cholesterol tests can be segmented By product high-density lipoprotein (HDL) tests, lipid profile, low-density lipoprotein (LDL) tests, point-of-care tests (POCT), total cholesterol tests, triglyceride tests. The lipid profile segment held the largest revenue share in 2021. Cholesterol tests market is further segmented By region Asia Pacific, Europe, North America, Rest of the World (RoW). Among these, North America was accounted for the highest revenue generator in 2021.

The global cholesterol tests market is highly competitive. The key players in the cholesterol tests market include Abbott Laboratories Inc., Danaher Corp., Horiba Ltd., Mindray Medical International Limited, Ortho Clinical Diagnostics Inc., Randox Laboratories Ltd., Roche Holding AG, Sekisui Diagnostics LLC, Siemens Healthineers, Thermo Fisher Scientific Inc.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
- Get a detailed picture of the Global Cholesterol Tests Market
- Identify segments/areas to invest in over the forecast period in the Global Cholesterol Tests Market
- Understand the competitive environment, the markets leading players
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
Part 1. Summary
Part 2. Introduction
Study period
Geographical scope
Market segmentation
Part 3. Cholesterol tests market overview
Part 4. Market breakdown by product
High-density lipoprotein (HDL) tests
Lipid profile
Low-density lipoprotein (LDL) tests
Point-of-care tests (POCT)
Total cholesterol tests
Triglyceride tests
Part 5. Market breakdown by region
Asia Pacific
Europe
North America
Rest of the World (RoW)
Part 6. Key companies
Abbott Laboratories, Inc.
Danaher Corp.
Horiba Ltd.
Mindray Medical International Limited
Ortho Clinical Diagnostics, Inc.
Randox Laboratories Ltd.
Roche Holding AG
Sekisui Diagnostics, LLC
Siemens Healthineers
Thermo Fisher Scientific, Inc.
Part 7. Methodology

Global Hematology Flow Cytometry Database

2024 Global Hematology and Flow Cytometry Database: US, Europe, Japan--Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts This database from provides the 2023 supplier shares, the 2023-2028

USD 14500 View Report

Global Hematology Market Shares Competitive Analysis

2023 Global Hematology Market Shares in the US, Europe, and Japan--Competitive Analysis of Leading and Emerging Market Players This new report provides hematology market shares for France, Germany, Italy, Japan,

USD 1450 View Report

Global Cholesterol Market 2023-2029

Cholesterol is a complex organic compound with the molecular formula C27H46O. It is a member of the biochemical family of compounds known as the lipids. Cholesterol serves as a precursor

USD 2650 View Report

Global Cholesterol Management Devices Market Research Report 2021-2025

Cholesterol is a type of lipid molecule, which is biosynthesized by all animal cells as it is an essential structural component of the cells. Cholesterol management devices are used to

USD 3200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available